Market Cap
$9.9B
BRKR
BRUKER CORP
$63.24 ▲ +2.10%
Prev close $61.94Market cap$9.9B
ConsensusBuy
12-mo target$62.25 (-1.6%)
▲ Bullish
Analyst conviction 6/10
Insider Selling Cluster (2 insiders)High Impact Filing (7/10)32 New Institutional Positions18 Institutional Exits Industrials & Manufacturing
Snapshot
The big-picture read on BRKR right now — valuation, ownership and activity at a glance.
Cap Size
Mid Cap
Analyst Consensus
Buy (62%)
Inst. Holders
50 funds
Inst. Value
$6.6B
Inst. Activity
32 buys / 18 sells
Insider Activity
$0.00 buy / $887.1K sell
Insider Net $
-$887.1K
SEC Reports
4
Price chart 30d +6.4%
Daily candles (open–high–low–close) with volume. Green = up day, red = down day.
No data for this timeframe.
Vol
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 1, 2026 short_volume
Short Volume: BRKR — 56.0% short (0.5M / 0.9M)
Short: 497,317 | Exempt: 1,077 | TRF Vol: 888,333 | Short Ratio: 56.0% | Off-exchange volume (dark p
Sep 15, 2026 Insider
Munch Mark acquired via exercise 2,000 shares
EXEC VP&PRES BRUKER NANO INC. @ $22.19 ($44.4K)
Sep 15, 2026 Insider
Aug 19, 2026 SEC Munch Mark sold 2,000 shares
EXEC VP&PRES BRUKER NANO INC. @ $52.87 ($105.7K)
Two divisional presidents at Bruker sold a combined $313K in open-market trades over a four-day window. The sales are sm
CLUSTER — Impact 2/10
Aug 17, 2026 Insider
Aug 14, 2026 SEC Pusch Wolfgang sold 3,473 shares
President BMID Group @ $56.90 ($197.6K)
Bruker Corporation declared a routine quarterly cash dividend of $0.05 per share on its common stock, payable October 7,
8-K — Impact 2/10
Bruker reported Q2 2026 revenue of $838.5M (+5.2% YoY, +2.8% organic), beating consensus of $853.6M on the top line. Non
8-K — Impact 7/10
Jun 30, 2026 Inst.
FMR LLC — ADD
20,237,425 shares ($1.2B)
Analyst ratings buy % -8.8%
How Wall Street rates the stock today, and the latest firm-by-firm actions.
62% rate it Buy or better · 21 analysts
Recent analyst actions
| Date | Firm | Action | Rating | Firm rating |
|---|---|---|---|---|
| Oct 1, 2026 | Guggenheim | MAINTAIN | Buy | 52% |
| Sep 29, 2026 | Leerink Partners | MAINTAIN | Outperform | 49% |
| Sep 9, 2026 | UBS | MAINTAIN | Neutral | 55% |
| Aug 5, 2026 | Citigroup | MAINTAIN | Neutral | 55% |
| Jul 8, 2026 | Citigroup | MAINTAIN | Neutral | 55% |
| Jul 7, 2026 | Leerink Partners | MAINTAIN | Outperform | 49% |
| Jun 29, 2026 | Guggenheim | MAINTAIN | Buy | 52% |
| Jun 24, 2026 | Barclays | MAINTAIN | Overweight | 54% |
| Jun 8, 2026 | JP Morgan | MAINTAIN | Overweight | 55% |
| May 7, 2026 | UBS | MAINTAIN | Neutral | 55% |
Monthly consensus history
| Period | Str. Buy | Buy | Hold | Sell | Str. Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | 6 | 7 | 7 | 1 | 0 | 62% | |
| Aug 1, 2026 | 6 | 8 | 6 | 1 | 0 | 67% | |
| Jul 1, 2026 | 6 | 8 | 6 | 1 | 0 | 67% | |
| Jun 1, 2026 | 7 | 7 | 7 | 1 | 0 | 64% | |
| May 1, 2026 | 7 | 7 | 7 | 1 | 0 | 64% | |
| Apr 1, 2026 | 7 | 8 | 6 | 1 | 0 | 68% | |
| Mar 1, 2026 | 7 | 8 | 6 | 1 | 0 | 68% | |
| Feb 1, 2026 | 7 | 8 | 6 | 1 | 0 | 68% |
Price targets
Where 12 covering analysts think BRKR trades over the next 12 months.
$62.25 -1.6% upside Hold
Current$63.24 Low$50.00 Median$61.00 High$80.00 12 analysts
$50.00$80.00
Analyst rating Buy· 2.2/5 as of Oct 2, 2026
Reports & filings
AI-scored summaries of recent SEC filings and press releases, with sentiment and impact.
4 SEC filing reports analyzed · 1 bullish, 0 bearish, 1 mixed, 2 neutral · avg impact 3.8/10.
NEUTRALCLUSTER2/10
Two divisional presidents at Bruker sold a combined $313K in open-market trades over a four-day wind
Aug 19, 2026
NEUTRAL8-K2/10
Bruker Corporation declared a routine quarterly cash dividend of $0.05 per share on its common stock
Aug 14, 2026
BULLISH8-K7/10
Bruker reported Q2 2026 revenue of $838.5M (+5.2% YoY, +2.8% organic), beating consensus of $853.6M
Aug 4, 2026
MIXEDINST-CLUSTER4/10
Institutional cluster in BRKR shows a mixed picture: six buyers added $170.4M in new positions (domi
Jun 11, 2026
Upcoming & catalyst events
Scheduled dates plus disclosed catalysts — earnings, dividends, enforcement, FDA and clinical-trial events. Colored dot = impact.
Oct 1, 2026
short_volume
Short Volume: BRKR — 56.0% short (0.5M / 0.9M)
Short: 497,317 | Exempt: 1,077 | TRF Vol: 888,333 | Short Ratio: 56.0% | Off-exchange volume (dark pool + OTC)
Sep 30, 2026
short_volume
Short Volume: BRKR — 67.3% short (0.6M / 0.8M)
Short: 554,308 | Exempt: 0 | TRF Vol: 823,769 | Short Ratio: 67.3% | Off-exchange volume (dark pool + OTC)
Sep 29, 2026
short_volume
Short Volume: BRKR — 56.7% short (0.5M / 0.8M)
Short: 461,523 | Exempt: 0 | TRF Vol: 813,375 | Short Ratio: 56.7% | Off-exchange volume (dark pool + OTC)
Sep 28, 2026
short_volume
Short Volume: BRKR — 70.0% short (0.8M / 1.2M)
Short: 822,546 | Exempt: 0 | TRF Vol: 1,175,275 | Short Ratio: 70.0% | Off-exchange volume (dark pool + OTC)
Sep 25, 2026
short_volume
Short Volume: BRKR — 68.1% short (0.7M / 1.1M)
Short: 714,730 | Exempt: 0 | TRF Vol: 1,050,215 | Short Ratio: 68.1% | Off-exchange volume (dark pool + OTC)
Earnings estimates
Forecast earnings per share and revenue by period — and whether estimates are rising.
| Period | EPS Est. | Range | Growth | 30d Rev | Up/Dn | Revenue | # |
|---|---|---|---|---|---|---|---|
| Current Q | $0.42 | $0.39–$0.45 | -7.4% | -0.2% | 0↑ 11↓ | $0.9B | 12 |
| Next Q | $0.90 | $0.88–$0.91 | 53.0% | +0.2% | 11↑ 0↓ | $1.0B | 12 |
| Current FY | $2.12 | $2.10–$2.13 | 15.9% | -0.1% | 5↑ 5↓ | $3.6B | 13 |
| Next FY | $2.39 | $2.17–$2.53 | 12.8% | -0.6% | 3↑ 8↓ | $3.7B | 13 |
Current-quarter EPS estimate — revision history
| When | EPS estimate | Change vs now |
|---|---|---|
| Current | $0.416 | — |
| 7d ago | $0.420 | -0.003 |
| 30d ago | $0.417 | -0.001 |
| 60d ago | $0.551 | -0.134 |
| 90d ago | $0.550 | -0.134 |
Institutional ownership
Which big funds own BRKR (from quarterly 13F filings) and who is adding or trimming.
50 institutional holders with $6.6B total value (110,431,023 shares) as of 2026-Q2. Top holders: FMR, Orbis, BlackRock,. Net buying activity: 32 institutions added/increased vs 18 reduced.
Top holders — 2026-Q2
| Fund | Shares | Value | % Tracked | Last move |
|---|---|---|---|---|
| FMR LLC | 20,237,425 | $1.2B | 18.3% | ADD +25.7% |
| Orbis Allan Gray Ltd | 17,940,076 | $1.1B | 16.2% | — |
| BlackRock, Inc. | 11,407,332 | $686.5M | 10.3% | — |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 4,888,290 | $294.2M | 4.4% | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 4,859,252 | $292.4M | 4.4% | — |
| Sculptor Capital LP | 4,625,000 | $278.3M | 4.2% | ADD +41.4% |
| STATE STREET CORP | 4,017,673 | $241.9M | 3.6% | — |
| FRANKLIN RESOURCES INC | 3,229,337 | $194.3M | 2.9% | — |
| Sachem Head Capital Management LP | 2,915,000 | $175.4M | 2.6% | NEW |
| DIMENSIONAL FUND ADVISORS LP | 2,610,051 | $157.1M | 2.4% | — |
Recent position changes
| Fund | Action | Prev | Current | Change | Value |
|---|---|---|---|---|---|
| FMR LLC | ADD | 16,101,803 | 20,237,425 | +25.7% | $1.2B |
| Sculptor Capital LP | ADD | 3,270,000 | 4,625,000 | +41.4% | $278.3M |
| Sachem Head Capital Management LP | NEW | — | 2,915,000 | — | $175.4M |
| FIRST TRUST ADVISORS LP | ADD | 1,493,053 | 2,065,984 | +38.4% | $124.3M |
| Alyeska Investment Group, L.P. | ADD | 757,157 | 1,410,164 | +86.2% | $84.9M |
| GOLDMAN SACHS GROUP INC | DOUBLED | 559,829 | 1,142,909 | +104.2% | $68.8M |
| M&G Plc | TRIM | 1,655,672 | 1,125,556 | -32.0% | $67.5M |
| VIKING GLOBAL INVESTORS LP | NEW | — | 893,491 | — | $53.8M |
| Candriam S.C.A. | TRIM | 676,424 | 411,700 | -39.1% | $24.8M |
| NOMURA HOLDINGS INC | NEW | — | 387,889 | — | $23.3M |
Insider activity
Buying and selling by company executives and directors (SEC Form 4).
8 insiders, 41 transactions. Net -$887.1K — $0.00 bought, $887.1K sold.
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 15, 2026 | Munch Mark | EXEC VP&PRES BRUKER NANO INC. | EXERCISE | 2,000 | $22.19 | $44.4K |
| Sep 15, 2026 | Munch Mark | EXEC VP&PRES BRUKER NANO INC. | SELL | 2,000 | $52.87 | $105.7K |
| Aug 17, 2026 | Pusch Wolfgang | President BMID Group | SELL | 3,473 | $56.90 | $197.6K |
| Aug 15, 2026 | Srega Juergen | PRESIDENT CALID | AWARD | 16,898 | — | — |
| Aug 15, 2026 | LAUKIEN FRANK H | PRESIDENT & CEO | TAX W/H | 4,760 | $57.70 | $274.7K |
| Aug 15, 2026 | Herman Gerald N | EXECUTIVE VICE PRESIDENT, CFO | TAX W/H | 2,724 | $57.70 | $157.2K |
| Aug 15, 2026 | Bures Thomas | Chief Accounting Officer | AWARD | 4,035 | — | — |
| Aug 15, 2026 | Munch Mark | EXEC VP&PRES BRUKER NANO INC. | AWARD | 14,443 | — | — |
| Aug 15, 2026 | Munch Mark | EXEC VP&PRES BRUKER NANO INC. | AWARD | 11,708 | — | — |
| Aug 15, 2026 | LAUKIEN FRANK H | PRESIDENT & CEO | AWARD | 29,463 | — | — |
Short interest & halts
FINRA semi-monthly short positions, Reg SHO threshold status, and recent trading halts for BRKR.
Shares short
12,490,387
Settlement Sep 15, 2026
Change vs prior
+4.0%
Semi-monthly cycle
Days to cover
6.3
At avg daily volume
Of shares outstanding
≈8.2%
Estimate — not % of float
All BRKR filing & press-release reports (4)
- CLUSTER reportAug 19, 2026
- 8-K reportAug 14, 2026
- 8-K reportAug 4, 2026
- INST-CLUSTER reportJun 11, 2026